Strategies for increasing drug delivery to the brain: Focus on brain lymphomaSIEGAL, Tali; ZYLBER-KATZ, Ester.Clinical pharmacokinetics. 2002, Vol 41, Num 3, pp 171-186, issn 0312-5963Article

CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?SIEGAL, Tali; GOLDSCHMIDT, Neta.Blood reviews. 2012, Vol 26, Num 3, pp 97-106, issn 0268-960X, 10 p.Article

Chemotherapy as initial treatment in gliomatosis cerebri: Results with temozolomideLEVIN, Netta; GOMORI, John Moshe; SIEGAL, Tali et al.Neurology. 2004, Vol 63, Num 2, pp 354-356, issn 0028-3878, 3 p.Article

Late-delayed cerebral involvement in systemic non-hodgkin lymphoma: A second primary tumor or a tardy recurrence?LOSSOS, Alexander; ASHHAB, Yaqoub; SVERDLIN, Elena et al.Cancer. 2004, Vol 101, Num 8, pp 1843-1849, issn 0008-543X, 7 p.Article

Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O⁶-methylguanine-ΔΝΑ-methyltransferaseLAVON, Iris; FUCHS, Dana; ZRIHAN, Daniel et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8952-8959, issn 0008-5472, 8 p.Article

Progressive low-grade oligodendrogliomas : Response to temozolomide and correlation between genetic profile and O⁶-methylguanine DNA methyltransferase protein expressionLEVIN, Netta; LAVON, Iris; ZELIKOVITSH, Bracha et al.Cancer. 2006, Vol 106, Num 8, pp 1759-1765, issn 0008-543X, 7 p.Article

CSF analysis of IgH gene rearrangement in CNS lymphoma : Relationship to the disease courseEKSTEIN, Dana; BEN-YEHUDA, Dina; SLYUSAREVSKY, Elena et al.Journal of the neurological sciences. 2006, Vol 247, Num 1, pp 39-46, issn 0022-510X, 8 p.Article

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma : an International Primary CNS Lymphoma Collaborative Group reportDOOLITTLE, Nancy D; ABREY, Lauren E; SCHIFF, David et al.Blood. 2008, Vol 111, Num 3, pp 1085-1093, issn 0006-4971, 9 p.Article

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group reportTAYLOR, Jennie W; FLANAGAN, Eoin P; HOANG-XUAN, Khe et al.Neurology. 2013, Vol 81, Num 19, pp 1690-1696, issn 0028-3878, 7 p.Article

Extrathymic malignancies in patients with myasthenia gravisLEVIN, Netta; ABRAMSKY, Oded; LOSSOS, Alexander et al.Journal of the neurological sciences. 2005, Vol 237, Num 1-2, pp 39-43, issn 0022-510X, 5 p.Article

Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional ExperienceANGELOV, Lilyana; DOOLITTLE, Nancy D; HEDRICK, Nancy A et al.Journal of clinical oncology. 2009, Vol 27, Num 21, pp 3503-3509, issn 0732-183X, 7 p.Article

Chemotherapy delivery issues in central nervous system malignancy: A reality checkMULDOON, Leslie L; SOUSSAIN, Carole; NEUWELT, Edward A et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2295-2305, issn 0732-183X, 11 p.Article

Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportGRISARIU, Sigal; AVNI, Batia; SHALOM, Edna et al.Blood. 2010, Vol 115, Num 24, pp 5005-5011, issn 0006-4971, 7 p.Article

Role of Intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvementSMITH, Justine R; ROSENBAUM, James T; WILSON, David J et al.Ophthalmology (Rochester, MN). 2002, Vol 109, Num 9, pp 1709-1716, issn 0161-6420Article